论文部分内容阅读
业已证明,部分的骨髓增生异常综合征(MDS)患者的骨髓T 淋巴细胞有抑制造血的作用;抑制粒细胞生成的T 细胞对糖皮质激素敏感,因而提出在体外对激素的反应可预测治疗效果。但至今还未确定这些T 细胞的亚群。此外还发现42%的病人对
It has been demonstrated that bone marrow T lymphocytes in some patients with myelodysplastic syndromes (MDSs) have hematopoietic inhibitory effects; that granulocyte-producing T cells inhibit glucocorticoid sensitivity and therefore suggest that the response to hormones in vitro can predict therapeutic effects . But so far no subset of these T cells has been identified. In addition, 42% of patients were also found